These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7786789)
1. Refractory cytopenia with t(1;7),+8 abnormality and dysplastic eosinophils showing intranuclear Charcot-Leyden crystals: a fluorescence in situ hybridization study. Ma SK; Wong KF; Chan JK; Kwong YL Br J Haematol; 1995 May; 90(1):216-8. PubMed ID: 7786789 [TBL] [Abstract][Full Text] [Related]
2. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia. La Starza R; Trubia M; Testoni N; Ottaviani E; Belloni E; Crescenzi B; Martelli M; Flandrin G; Pelicci PG; Mecucci C Haematologica; 2002 Aug; 87(8):789-94. PubMed ID: 12161353 [TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndrome with myelofibrosis and basophilia: detection of trisomy 8 in basophils by fluorescence in-situ hybridization. Ma SK; Chan JC; Wan TS; Chan AY; Chan LC Leuk Lymphoma; 1998 Oct; 31(3-4):429-32. PubMed ID: 9869209 [TBL] [Abstract][Full Text] [Related]
4. A case of chronic myelomonocytic leukemia with severe eosinophilia having t(5;12)(q31;p13) with t(1;7)(q10;p10). Kim M; Lim J; Lee A; Park G; Kim Y; Han K; Kang CS; Kim YJ; Song JS Acta Haematol; 2005; 114(2):104-7. PubMed ID: 16103634 [TBL] [Abstract][Full Text] [Related]
5. Identification of Charcot-Leyden crystals by electron microscopy. Carson HJ; Buschmann RJ; Weisz-Carrington P; Choi YS Ultrastruct Pathol; 1992; 16(4):403-11. PubMed ID: 1502737 [TBL] [Abstract][Full Text] [Related]
6. Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH). Han K; Lee W; Harris CP; Kim W; Shim S; Meisner LF Leukemia; 1994 Jan; 8(1):81-6. PubMed ID: 8289503 [TBL] [Abstract][Full Text] [Related]
7. A unique clone involving multiple structural chromosome rearrangements in a myelodysplastic syndrome case. Yan J; Whittom R; Delage R; Drouin R Cancer Genet Cytogenet; 2003 Jan; 140(2):138-44. PubMed ID: 12645652 [TBL] [Abstract][Full Text] [Related]
8. Late appearance of t(1;19)(q11;q11) in myelodysplastic syndrome associated with dysplastic eosinophilia and pulmonary alveolar proteinosis. Ando J; Tamayose K; Sugimoto K; Oshimi K Cancer Genet Cytogenet; 2002 Nov; 139(1):14-7. PubMed ID: 12547151 [TBL] [Abstract][Full Text] [Related]
9. A case of myelodysplasia with eosinophilia having a translocation t(5;12) (q31;q13) restricted to myeloid cells but not involving eosinophils. Jani K; Kempski HM; Reeves BR Br J Haematol; 1994 May; 87(1):57-60. PubMed ID: 7947256 [TBL] [Abstract][Full Text] [Related]
11. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Weller PF; Goetzl EJ; Austen KF Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7440-3. PubMed ID: 6261258 [TBL] [Abstract][Full Text] [Related]
12. Charcot-Leyden crystals: pathology and diagnostic utility. Pantanowitz L; Balogh K Ear Nose Throat J; 2004 Jul; 83(7):489-90. PubMed ID: 15372922 [TBL] [Abstract][Full Text] [Related]
13. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. Bernell P; Jacobsson B; Nordgren A; Hast R Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444 [TBL] [Abstract][Full Text] [Related]
14. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein. Dvorak AM; Furitsu T; Letourneau L; Ishizaka T; Ackerman SJ Am J Pathol; 1991 Jan; 138(1):69-82. PubMed ID: 1987770 [TBL] [Abstract][Full Text] [Related]
15. Significance of Charcot Leyden crystals in liver cytology-A case report. Thakral D; Agarwal P; Saran RK; Saluja S Diagn Cytopathol; 2015 May; 43(5):392-4. PubMed ID: 25350873 [TBL] [Abstract][Full Text] [Related]
16. Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia. Enright H; Weisdorf D; Peterson L; Rydell RE; Kaplan ME; Arthur DC Leukemia; 1992 May; 6(5):381-4. PubMed ID: 1593903 [TBL] [Abstract][Full Text] [Related]
17. Charcot-Leyden crystals in fine needle aspiration cytology. Arora VK; Singh N; Bhatia A Acta Cytol; 1997; 41(2):409-12. PubMed ID: 9100774 [TBL] [Abstract][Full Text] [Related]
18. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome. Dvorak AM; Weller PF; Monahan-Earley RA; Letourneau L; Ackerman SJ Lab Invest; 1990 May; 62(5):590-607. PubMed ID: 2160562 [TBL] [Abstract][Full Text] [Related]
19. AML with inv(16) with numerous Charcot-Leyden crystals. Dwyre DM; Osman M Blood; 2019 Nov; 134(21):1876. PubMed ID: 31751481 [No Abstract] [Full Text] [Related]
20. Abnormalities of chromosome 16 in association with acute myelomonocytic leukemia and dysplastic bone marrow eosinophils. Hogge DE; Misawa S; Parsa NZ; Pollak A; Testa JR J Clin Oncol; 1984 Jun; 2(6):550-7. PubMed ID: 6587018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]